Former pharmaceutical CEO Martin Shkreli says he'd like to ``berate'' and ``insult'' Congress -- but instead will take the Fifth Amendment during questioning on Thursday.
The former Turing Pharmaceuticals CEO, who's reviled for hiking the price of a lifesaving drug, spoke Tuesday on Fox Business. Shkreli said that instead of invoking his right against self-incrimination, as planned, he would ``love to talk to Congress.'' He says he would ``berate them'' and ``insult them.''
Meanwhile, his new lawyer, Benjamin Brafman, issued a statement expressing confidence that Shkreli will be exonerated in his federal court case. He'll have a routine court appearance Wednesday in New York.
In December, the former hedge fund manager was charged with securities fraud and conspiracy related to another pharmaceutical company he previously ran, Retrophin.